000			00899 a2200241 4500
003			OSt
005			20240229113924.0
008			240221b |||||||| |||| 00| 0 eng d
020			_a9789351072720
040			_cCUS
082			_a615.19 _bSIL/O
100			_aSilverman, Richard B _925768
245			_aThe Organic Chemistry of Drug Design and Drug Action
260			_aLondon: _bElsevier, _c2022.
300			_a517p.
505			_aIntroduction Lead discovery and lead modification Receptors Enzymes Enzyme inhibition and inactivation Dna-interactive agents Drug resistance and drug synergism Drug metabolism Prodrugs and drug delivery systems
650			_aOrganic chemistry of drug design and drug action _925769
650			_adrug synergism _925770
650			_aEnzymes _918671
650			_aEnzyme inhibition _925771
700			_aHolladay, Mark W. _925772
942			_2ddc _cWB16
999			_c214046 _d214046